Latest Stories
Guest Editorial
Last November, the American public voted on America First causes, which include the greatest scientific discovery and achievement enterprise in the world: The National Institutes of Health. NIH has made America first in biomedical science for the past century.
Book ReviewFree
I accumulated some books I found interesting over the last several months, knowing I would eventually take time off on vacation and have a chance to delve into them more than my schedule normally allows.
Guest Editorial
From the time of its inception, the Worldwide Innovative Network (WIN) Consortium in precision cancer medicine has had a bold mission to significantly improve survival of patients with cancer across the world through international collaboration.
Book ReviewFree
I had fun reading and sharing some book reviews with The Cancer Letter previously, and I thought I would try again with a new installment (The Cancer Letter, Aug. 6, 2021).
FreeGuest Editorial
I have no doubt that our professional associations in cancer research and oncology and our NCI in the U.S. care about the plight of cancer scientists and oncologists who have been displaced due to war or violence in their home countries.
FreeGuest Editorial
It’s been a hot summer all over the world, but our work doesn’t stop as our problems need solutions.
FreeGuest Editorial
It was awe-inspiring to see how quickly the world’s science came together to address the COVID-19 pandemic—and much was learned. Academic institutions, big pharma, government, and foundations stepped up to do everything possible in an unprecedented way. Two years later, the results are evident as life is returning to normal.
Cancer History ProjectFree
In 1974, The Cancer Letter published a story listing seven proposed “laws” postulated by of one of oncology’s wise men, Emil J Freireich (The Cancer Letter, May 14, 1976).
Book ReviewFree
Over the past year, I noticed several books written by giants in our field, people everyone knows, people I am honored to know personally. I was interested in what they wrote, and I thought their books would be of general interest to The Cancer Letter community.
Guest Editorial
At a recent NIH study section that I chaired, we had many applications that we reviewed as a group before the meeting. At the meeting, we were required to discuss over 50% of the grants.
